X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216404
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214277
https://health.economictimes.indiatimes.com/news/pharma/unichem-gets-usfda-nod-for-generic-medication/93731676
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213284
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216594
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-19-2022-1642582122.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-29-2021-1632907538.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214328
https://www.business-standard.com/article/economy-policy/nppa-allows-50-price-hike-for-ibuprofen-ranitidine-carbamazepine-121070300071_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213311
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-22-2020-1595395565.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-10-2020-1591766845.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211623
https://www.indiainfoline.com/article/news-top-story/j-b-chemicals-gets-usfda-nod-for-carbamazepine-extended-release-tablets-stock-spurts-2-120042700104_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207798
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-21-2019-1566366765.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205571
http://www.pharmatimes.com/news/real_world_data_back_use_of_eisai,_bials_zebinix_in_epilepsy_1214415
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-8-2017-1510120910.pdf
https://www.in-pharmatechnologist.com/Article/2017/10/17/GT-Biopharma-starts-making-carbamazepine-tabets-for-planned-trials
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2017-1502256126.pdf
http://www.pharmatimes.com/news/eu_regulators_widen_approval_for_zebinix_1194295
http://www.pharmaceutical-journal.com/news-and-analysis/news/lacosamide-has-potential-as-first-line-monotherapy-for-newly-diagnosed-epilepsy/20202031.article
https://www.statnews.com/pharmalot/2016/11/01/novartis-colombia-drug-prices/
https://globenewswire.com/news-release/2016/10/07/878046/0/da/US-FDA-godkender-Carnexiv-carbamazepin-i-injektionsform-som-intraven%C3%B8s-erstatningsterapi-for-orale-carbamazepin-formuleringer.html
https://www.pharmacompass.com/pdf/news/lundbecks-carnexiv-carbamazepine-receives-tentative-approval-in-us-1476274089.pdf
https://www.pharmacompass.com/pdf/news/validus-pharms-equetro-carbamazepine-approved-in-us-1474959728.pdf
http://www.pharma-excipients.ch/2016/04/20/optimization-of-hot-melt-extrusion-parameters-for-sphericity-and-hardness-of-polymeric-face-cut-pellets/
http://www.prnewswire.com/news-releases/once-a-day-epilepsy-drug-may-prevent-seizures-as-well-as-twice-a-day-drug-300251929.html
http://www.prnewswire.com/news-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment-569850931.html
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+suspende+lotes+de+anticonvulsivante+e+anticoncepcional
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+determina+a+suspensao+de+dois+lotes+de+medicamentos
Market Place
Share 
